WASHINGTON, DC Congressman Bernie Sanders (I-VT) joined with five
House members at a press conference today to address their growing concern
over the direction of the Medicare debate in Congress. Their message was
simple only by lowering the price of prescription drugs in the U.S. can
Congress develop a truly strong and comprehensive Medicare prescription
drug benefit with a reasonable price tag.
Sanders said, By refusing to stand up to the pharmaceutical industry
and lower the outrageously high cost of prescription drugs, most of the
Medicare prescription drug proposals now being floated in Congress will be
far too expensive for most senior citizens. While the Republican plans are
grossly inadequate, the major Democratic plan is also unsatisfactory. I do
not believe that most seniors in this country will feel positive about a
Democratic plan that would contain a $53 a month premium, a $250
deductible and a 50% co-pay on all drugs up to an out-of-pocket limit of
$3,500. Even with the catastrophic coverage this bill contains, this
proposal is just too expensive. It makes no sense that after federal
government spending of $30 billion a year on this program, most seniors in
Vermont and throughout the country would be much better off by just going
over the border and buying their medicine in Canada.
Sanders continued, The members of Congress who stand with me today
want to create a strong prescription drug benefit under Medicare. We
understand, however, that to do that we must end the absurdity of American
consumers and the U.S. government being forced to pay, by far, the highest
prices in the world for prescription drugs. Clearly, this will not be an
easy task given the $262 million that the drug industry spent in the
1999-2000 election cycle, a sum which will only go up in the coming years.
But its a fight that must be waged, and a fight that must be won.
Sanders is the author of a Medicare prescription drug benefit bill
which would provide a 20% co-pay, a low deductible and low premiums. His
legislation is able to be far more generous than any other because of the
strong cost-containment built into it, including a prescription drug
reimportation approach that would lower the costs of drugs for Medicare by
40-50 percent.
For More Information:
Visit the PRESCRIPTIONS
section.
Contact:
HELEN LANGAN at (202)
225-4115